Publication | Closed Access

Methylenetetrahydrofolate Reductase Polymorphism (677 C>T) Predicts Long Time to Progression in Metastatic Colon Cancer Treated with 5-Fluorouracil and Folinic Acid

Long TimeMedicineFolinic AcidColorectal CancerPathologyCancer GenomicsCancer GeneticsMethylenetetrahydrofolate Reductase PolymorphismOncologyRadiation OncologyCancer Research